104 related articles for article (PubMed ID: 9107564)
1. Human cytokines suppress apoptosis of leukaemic CD5+ B cells and preserve expression of bcl-2.
Tangye SG; Raison RL
Immunol Cell Biol; 1997 Apr; 75(2):127-35. PubMed ID: 9107564
[TBL] [Abstract][Full Text] [Related]
2. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
[TBL] [Abstract][Full Text] [Related]
5. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis.
Gottardi D; Alfarano A; De Leo AM; Stacchini A; Aragno M; Rigo A; Veneri D; Zanotti R; Pizzolo G; Caligaris-Cappio F
Br J Haematol; 1996 Sep; 94(4):612-8. PubMed ID: 8826882
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
Jewell AP
Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
[TBL] [Abstract][Full Text] [Related]
7. CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC.
Perez-Chacon G; Vargas JA; Jorda J; Morado M; Rosado S; Martin-Donaire T; Losada-Fernandez I; Rebolleda N; Perez-Aciego P
Leuk Res; 2007 Feb; 31(2):183-93. PubMed ID: 16725198
[TBL] [Abstract][Full Text] [Related]
8. [Apoptosis in chronic lymphocytic leukemia].
Giordano M
Medicina (B Aires); 2000; 60 Suppl 2():12-6. PubMed ID: 11188924
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine ability to down-regulate Bcl-2 gene product in CD5+ leukaemic B cells: in vitro/in vivo correlations.
Gottardi D; De Leo AM; Alfarano A; Stacchini A; Circosta P; Gregoretti MG; Bergui L; Aragno M; Caligaris-Cappio F
Br J Haematol; 1997 Oct; 99(1):147-57. PubMed ID: 9359515
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia.
Cioca DP; Kitano K
Leukemia; 2002 Mar; 16(3):335-43. PubMed ID: 11896536
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of the FAS antigen in B chronic lymphocytic leukemia and hairy cell leukemia.
Panayiotidis P; Ganeshaguru K; Foroni L; Hoffbrand AV
Leukemia; 1995 Jul; 9(7):1227-32. PubMed ID: 7543175
[TBL] [Abstract][Full Text] [Related]
12. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells.
Defrance T; Vanbervliet B; Durand I; Banchereau J
Eur J Immunol; 1989 Feb; 19(2):293-9. PubMed ID: 2467815
[TBL] [Abstract][Full Text] [Related]
13. Leukaemic CD5+ B-cell apoptosis: co-incidence of cell death and DNA fragmentation with reduced bcl-2 expression.
Tangye SG; Raison RL
Br J Haematol; 1996 Mar; 92(4):950-3. PubMed ID: 8616092
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
Dancescu M; Rubio-Trujillo M; Biron G; Bron D; Delespesse G; Sarfati M
J Exp Med; 1992 Nov; 176(5):1319-26. PubMed ID: 1402678
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.
Nilsson J; Söderberg O; Nilsson K; Rosén A
Blood; 2000 Feb; 95(4):1420-6. PubMed ID: 10666220
[TBL] [Abstract][Full Text] [Related]
16. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.
Pers JO; Berthou C; Porakishvili N; Burdjanadze M; Le Calvez G; Abgrall JF; Lydyard PM; Youinou P; Jamin C
Leukemia; 2002 Jan; 16(1):44-52. PubMed ID: 11840262
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.
Chaouchi N; Wallon C; Taieb J; Auffredou MT; Tertian G; Lemoine FM; Delfraissy JF; Vazquez A
Clin Immunol Immunopathol; 1994 Nov; 73(2):197-204. PubMed ID: 7923926
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia.
Goolsby C; Paniagua M; Tallman M; Gartenhaus RB
Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1994 Jan; 86(1):169-73. PubMed ID: 8011526
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo.
Jewell AP; Worman CP; Lydyard PM; Yong KL; Giles FJ; Goldstone AH
Br J Haematol; 1994 Oct; 88(2):268-74. PubMed ID: 7803269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
